Skip to main content

Advertisement

SpringerLink
Log in

Cytokines and adhesion molecules in the pathogenesis of vasculitis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

Upregulated adhesion molecule and cytokine expression on endothelial cells and infiltrating inflammatory cells occur in most vasculitis syndromes. These observations suggest that vasculitis is associated with pathologic activation of normal immune cell cytokine cascades. Abnormal expression of adhesion molecules and cytokines in vascular endothelium is a manifestation of endothelial dysfunction that can be triggered by a variety of stimuli, including infectious agents, immune complexes, and antiendothelial cell antibodies. Dysregulated adhesion molecule expression, uncontrolled inflammation, thrombosis, and vessel occlusion lead to the clinical manifestations of vasculitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cines DB, Pollak ES, Buck CA, et al.:Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527–3561. Comprehensive review of normal and pathologic endothelial cell function across the spectrum of human diseases.

    PubMed  CAS  Google Scholar 

  2. Bradley JR, Lockwood CM, Thiru S: Endothelial cell activation in patients with systemic vasculitis. QJM 1994, 87:741–745.

    PubMed  CAS  Google Scholar 

  3. Burrows NP, Molina FA, Terenghi G, et al.:Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis. J Clin Pathol 1994, 47:939–944.

    PubMed  CAS  Google Scholar 

  4. Papa ND, Raschi E, Moroni G, et al.:Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a proadhesive and a proinflammatory phenotype in vitro. Lupus 1999, 8:423–429.

    Article  PubMed  CAS  Google Scholar 

  5. Sundy JS, Haynes BF: Vasculitis: pathogenic mechanisms of vessel damage. In Inflammation: Basic Principles and Clinical Correlates, Edited by Gallin JI, Snyderman R, Fearon DT, et al. Philadelphia: Lippincott Williams & Wilkins; 1999:1335.

    Google Scholar 

  6. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994, 121:484–491.

    PubMed  CAS  Google Scholar 

  7. Frassanito MA, Dammacco R, Cafforio P, Dammacco F: Th1 polarization of the immune response in BehÇet’s disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999, 42:1967–1974.

    Article  PubMed  CAS  Google Scholar 

  8. Yoshioka T, Matsutani T, Iwagami S, et al.:Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology 1999, 96:465–472.

    Article  PubMed  CAS  Google Scholar 

  9. Csernok E, Trabandt A, Muller A, et al.:Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999, 42:742–750.

    Article  PubMed  CAS  Google Scholar 

  10. Kojima K, Omoto E, Katayama Y, et al.:Autoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome). Int J Hematol 1996, 63:149–154.

    Article  PubMed  CAS  Google Scholar 

  11. Tsukadaira A, Okubo Y, Kitano K, et al.:Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome. Allergy Asthma Proc 1999, 20:39–44.

    Article  PubMed  CAS  Google Scholar 

  12. Maeno N, Takei S, Masuda K, et al.:Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998, 44:596–599.

    Article  PubMed  CAS  Google Scholar 

  13. Terai M, Yasukawa K, Narumoto S, et al.:Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 1999, 83:337–339.

    Article  PubMed  CAS  Google Scholar 

  14. Li CG, Reynolds I, Ponting JM, et al.:Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis. Br J Rheumatol 1998, 37:1303–1306.

    Article  PubMed  CAS  Google Scholar 

  15. McCourt M, Wang JH, Sookhai S, Redmond HP: Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 1999, 134:1325–1331.

    Article  PubMed  CAS  Google Scholar 

  16. Kaiser M, Younge B, Bjornsson J, et al.:Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 1999, 155:765–774. Demonstrates that infiltrating inflammatory cells in giant cell arteritis are important in stimulating altered vessel function, which results in neoangiogenesis.

    PubMed  CAS  Google Scholar 

  17. Wong M, Silverman ED, Fish EN: Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease. J Rheumatol 1997, 24:1179–1185.

    PubMed  CAS  Google Scholar 

  18. Fong AM, Robinson LA, Steeber DA, et al.:Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998, 188:1413–1419.

    Article  PubMed  CAS  Google Scholar 

  19. Muller-Kobold AC, Kallenberg CG, Tervaert JW: Monocyte activation in patients with Wegener’s granulomatosis. Ann Rheum Dis 1999, 58:237–245.

    Article  PubMed  CAS  Google Scholar 

  20. Igarashi H, Hatake K, Tomizuka H, et al.:High serum levels of M-CSF and G-CSF in Kawasaki disease. Br J Haematol 1999, 105:613–615.

    Article  PubMed  CAS  Google Scholar 

  21. Terai M, Jibiki T, Harada A, et al.:Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 1999, 65:566–572.

    PubMed  CAS  Google Scholar 

  22. Weyand CM, Fulbright JW, Evans JM, et al.:Corticosteroid requirements in polymyalgia rheumatica. Arch Intern Med 1999, 159:577–584.

    Article  PubMed  CAS  Google Scholar 

  23. John S, Neumayer HH, Weber M: Serum circulating ICAM-1 levels are not useful to indicate active vasculitis or early renal allograft rejection. Clin Nephrol 1999, 42:369–375.

    Google Scholar 

  24. Tatsis E, Schnabel A, Gross WL: Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998, 129:370–374.

    PubMed  CAS  Google Scholar 

  25. Bochner BS: Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997, 100:581–585.

    Article  PubMed  CAS  Google Scholar 

  26. DeGraba TJ: The role of inflammation after acute stroke: utility of pursuing anti-adhesion molecule therapy. Neurology 1998, 51:S62-S68.

    PubMed  CAS  Google Scholar 

  27. Weyand CM, Goronzy JJ: Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999, 42:844–853. Thorough review summarizing the series of elegant experiments by Weyand et al. that have identified the pathogenic mechanisms of vessel damage in giant cell arteritis.

    Article  PubMed  CAS  Google Scholar 

  28. Weyand CM, Schonberger J, Oppitz U, et al.:Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994, 179:951–960.

    Article  PubMed  CAS  Google Scholar 

  29. Weyand CM, Tetzlaff N, Bjornsson J, et al.:Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997, 40:19–26. This is the first study that correlates clinical manifestations of vasculitis with distinct patterns of cytokine expression.

    Article  PubMed  CAS  Google Scholar 

  30. Rittner HL, Kaiser M, Brack A, et al.:Tissue-destructive macrophages in giant cell arteritis. Circ Res 1999, 84:1050–1058.

    PubMed  CAS  Google Scholar 

  31. Rittner HL, Hafner V, Klimiuk PA, et al.:Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999, 103:1007–1013.

    PubMed  CAS  Google Scholar 

  32. Murohara T, Buerke M, Lefer AM: Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: role of selectins. Arterioscler Thromb 1994, 14:1509–1519.

    PubMed  CAS  Google Scholar 

  33. Simon DI, Chen Z, Seifert P, et al.:Decreased neointimal formation in MAC-1 -/-mice reveals a role for inflammation in vascular repair after angioplasty. J Clin Invest 2000, 105:293–300. This study provides important evidence that inflammatory cells infiltrating vessels cause pathologic changes such as intimal hypertrophy.

    Article  PubMed  CAS  Google Scholar 

  34. Scalia R, Lefer AM: In vivo regulation of PECAM-1 activity during acute endothelial dysfunction in the rat mesenteric microvasculature. J Leukoc Biol 1998, 64:163–169.

    PubMed  CAS  Google Scholar 

  35. Gauthier TW, Scalia R, Murohara T, et al.:Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995, 15:1652–1659.

    PubMed  CAS  Google Scholar 

  36. Luvara G, Pueyo ME, Philippe M, et al.:Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler Thromb Vasc Biol 1998, 18:1408–1416.

    PubMed  CAS  Google Scholar 

  37. Cutfield R, Sharpe DN, Clarke ED: Captopril in the treatment of refractory high-renin hypertension. N Z Med J 1980, 91:424–426.

    PubMed  CAS  Google Scholar 

  38. Lakshminarayanan V, Beno DW, Costa RH, Roebuck KA:Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumor necrosis factoralpha in endothelial and epithelial cells. J Biol Chem 1997, 272:32910–32918.

    Article  PubMed  CAS  Google Scholar 

  39. Rahman A, Kefer J, Bando M, et al.:E-selectin expression in human endothelial cells by TNF-alpha-induced oxidant generation and NF-kappaB activation. Am J Physiol 1998, 275:L533-L544.

    PubMed  CAS  Google Scholar 

  40. Greer IA, Lyall F, Perera T, et al.:Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994, 84:937–940.

    PubMed  CAS  Google Scholar 

  41. Noris M, Ruggenenti P, Todeschini M, et al.:Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. Am J Kidney Dis 1996, 27:790–796.

    PubMed  CAS  Google Scholar 

  42. Schersten H, Kirno K, Ekroth R, et al.:Impaired endotheliummediated vasodilatation in the peripheral vasculature of patients with acute pulmonary allograft rejection. J Heart Lung Transplant 1996, 15:556–563.

    PubMed  CAS  Google Scholar 

  43. Weis M, Wildhirt SM, Schulze C, et al.:Modulation of coronary vasomotor tone by cytokines in cardiac transplant recipients. Transplantation 1999, 68:1263–1267.

    Article  PubMed  CAS  Google Scholar 

  44. Scalia R, Booth G, Lefer DJ: Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endotheliumderived nitric oxide. Faseb J 1999, 13:1039–1046.

    PubMed  CAS  Google Scholar 

  45. Boehme MW, Schmitt WH, Youinou P, et al.:Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener’s granulomatosis and other systemic vasculitides. Am J Med 1996, 101:387–394.

    Article  PubMed  CAS  Google Scholar 

  46. Yamakawa R, Ishii M, Sugimura T, et al.:Coronary endothelial dysfunction after Kawasaki disease: evaluation by intracoronary injection of acetylcholine. J Am Coll Cardiol 1998, 31:1074–1080.

    Article  PubMed  CAS  Google Scholar 

  47. Mitani Y, Okuda Y, Shimpo H, et al.:Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997, 96:454–461.

    PubMed  CAS  Google Scholar 

  48. Makita S, Nakamura M, Murakami H, et al.:Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger’s disease). Circulation 1996, 94:II211-II215.

    PubMed  CAS  Google Scholar 

  49. Kaiser M, Weyand CM, Bjornsson J, Goronzy JJ: Plateletderived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998, 41:623–633. These experiments tease apart the cytokine pathways that result in intimal hyperplasia and subsequent vessel occlusion in giant cell arteritis.

    Article  PubMed  CAS  Google Scholar 

  50. Tuder RM, Voelkel NF: Pulmonary hypertension and inflammation. J Lab Clin Med 1998, 132:16–24.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Allergy, and Clinical Immunology, Duke University Medical Center, Room 348 Sands Building, Box 3278 DUMC, 27710, Durham, NC, USA

    John S. Sundy MD, PhD & Barton F. Haynes MD

Authors
  1. John S. Sundy MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barton F. Haynes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundy, J.S., Haynes, B.F. Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr Rheumatol Rep 2, 402–410 (2000). https://doi.org/10.1007/s11926-000-0040-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-000-0040-8

Keywords

Search

Navigation